Efavirenz compressed tablet formulation

Details Efavirenz compressed tablet formulation Efavirenz compressed tablet formulation

A - Human Necessities

61

K

A61K 31/535 (2006.01) A61K 9/20 (2006.01) A61K 9/28 (2006.01) A61P 31/18 (2006.01)

Patent

CA 2332876

This invention relates to a 50 % drug loaded compressed tablet formulation for efavirenz. Efavirenz is a non-nucleoside reverse trancriptase inhibitor being studied clinically for use in the treatment of HIV infections and AIDS.

L'invention concerne une formulation de comprimé d'efavirenz présentant 50 % de charge médicamenteuse. L'efavirenz est un inhibiteur de la transcriptase inverse non nucléoside actuellement étudié en clinique pour le traitement d'infections à VIH et du SIDA.

Affiliated with

Also associated with

Rating

Efavirenz compressed tablet formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Efavirenz compressed tablet formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Efavirenz compressed tablet formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1569201